Mona Al-DabbaghKeswadee LapphraRumi McGloinKelsey InrigH. Simon SchaafBen J. MaraisLaura SauveIan KitaiTobias R. KollmannThe University of British ColumbiaDepartment of PediatricsMahidol UniversityChildren's and Women's Health Centre of British ColumbiaUniversiteit StellenboschHospital for Sick Children University of Toronto2018-05-032018-05-032011-01-01Pediatric Infectious Disease Journal. Vol.30, No.6 (2011), 501-50515320987089136682-s2.0-79957998404https://repository.li.mahidol.ac.th/handle/20.500.14594/12775Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting. Copyright © 2011 by Lippincott Williams & Wilkins.Mahidol UniversityMedicineReviewSCOPUS10.1097/INF.0b013e31820b583d